Research History
0
Years of Research
Japanese Bacteriological Society × Cancer Society has been continuously researching Agaricus and its polysaccharide activity since 1980
0+
International Research Reports
Covering multiple cutting-edge medical directions including anti-tumor, immune regulation, and carbohydrate molecular activity
0+
National Research Institutions
Multiple institutions in Asia, Europe, and America have deeply verified the role of Agaricus extract in cancer adjuvant therapy
Expert Team

Professor Honjo
A renowned Japanese immunologist and 2018 Nobel laureate in Physiology or Medicine. Special Professor at Kyoto University's Institute for Advanced Study, pioneer of cancer immunotherapy.

Professor Gabazza Esteban
Special Professor at Mie University Graduate School of Medicine. Expert in immunology and respiratory medicine, lead developer of CP-101.
Real Case Studies
"I Thought My Voice Was Gone Forever" — Life Reversal and Scientific Insights of a Japanese Malignant Lymphoma Patient After Persistent Immunointervention
62-year-old Ichiro Sato (pseudonym) is a key member of a local community choir, known for his powerful voice and regarded by friends as the "soul" of the group.Read more"I Thought It Was All Over" — The Story of a Japanese Breast Cancer Patient's Reversal Through Persistent Immune Intervention and the Scientific Evidence Behind It
Keiko Morita, 44, Japan: 'Had I not kept taking CP-101 back then, I doubt I would have made it to this day. It isn't a miracle, but it gave me back the strength to keep fighting my cancer.' She found, on the brink of despair, the will to battle her disease once more.Read more
News Center
- 2024-12-20CP-101 Shines at Shenzhen International Nutrition and Health Industry Exhibition, Exploring Life Health Science Frontiers and Leading Industry Trends!Learn More
- 2024-11-01Cancer Mutual Aid Research Promotion Charity Foundation Launch Ceremony Successfully Held in Tokyo, Japan!Learn More
- 2025-03-01Death of 41-year-old Female Professor at South China Normal University Reveals Harsh Reality: Cancer Targets Young People!Learn More